Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples